Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
TAZMO, Last Fiscal Year Ordinary Profit Revised Upward by 33%, Raises Record High Profit Forecast
6266 TAZMO CO.,LTD 【J-GAAP】
Guidance Update ReportTAZMO CO.,LTD <6266> [TSE Prime] announced a performance revision after the market closed on February 10th (15:30). The consolidated ordinary profit for the fiscal year ending December 2024 has been revised upward 33.3%, from the previous forecast of 4.5 billion yen to 5.99 billion yen (compared to 3.89 billion yen in the previous period), increasing the growth rate from 15.7% to 54.2%, further surpassing the previous forecast of record-high profits for four consecutive terms.
Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the July to December period (2H) consolidated ordinary profit has been revised upward 98.6%, from the previous forecast of 1.51 billion yen to 3.01 billion yen (compared to 3.18 billion yen in the same period of the previous year), and the declining rate is expected to decrease from 52.3% to 5.2%.
Kabutan News
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2024 Prev | 19,761 | 1,764 | 1,519 | 993 | 67.8 | 30 | Aug 6, 2024 | J-GAAP |
Jul - Dec, 2024 New | 19,626 | 3,081 | 3,017 | 2,180 | 148.8 | 30 | Feb 10, 2025 | J-GAAP |
Revision Rate | -0.7% | +74.7% | +98.6% | +119.5% | +119.7% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Prev | 36,000 | 4,600 | 4,500 | 3,060 | 208.8 | 30 | Feb 13, 2024 | J-GAAP |
Dec, 2024 New | 35,865 | 5,917 | 5,998 | 4,247 | 289.9 | 30 | Feb 10, 2025 | J-GAAP |
Revision Rate | -0.4% | +28.6% | +33.3% | +38.8% | +38.9% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2023 | 17,727 | 3,115 | 3,184 | 2,219 | 152.0 | 24 | Feb 13, 2024 | J-GAAP |
Jul - Dec, 2024 Guidance | 19,626 | 3,081 | 3,017 | 2,180 | 148.8 | 30 | Feb 10, 2025 | J-GAAP |
YoY | +10.7% | -1.1% | -5.2% | -1.8% | -2.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 24,356 | 2,806 | 3,138 | 2,263 | 162.1 | 21 | Feb 13, 2023 | J-GAAP |
Dec, 2023 | 28,161 | 3,654 | 3,890 | 2,356 | 161.3 | 24 | Feb 13, 2024 | J-GAAP |
Dec, 2024 Guidance | 35,865 | 5,917 | 5,998 | 4,247 | 289.9 | 30 | Feb 10, 2025 | J-GAAP |
YoY | +27.4% | +61.9% | +54.2% | +80.3% | +79.7% |
Related Articles
MARUYAMA MFG, Oct-Dec (1Q) Ordinary Profit Loss Widens
SoftBank Corp, Apr-Dec (Cumulative 3Q) Net Income Increases by 7%
NITTO KOGYO, Oct-Dec (3Q) Ordinary Profit Increases by 17%
DAITO KOUN, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 7%, Oct-Dec Ordinary Profit Increases by 25%
CELM Inc, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 7%, Oct-Dec Ordinary Profit Decreases by 10%
KOBAYASHI PHARMA, 43% Decrease in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
Immuno-Biological Lab, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.2 times, Exceeds Full-Year Plan
Nippon Carbon, 2% Increase in Ordinary Profit for The Current Fiscal Year
NISSAN TOKYO SALES, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 9%
Human Creation, Oct-Dec (1Q) Ordinary Profit Increases by 53%